Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
|||||||
GSE214633 |
A flexible model for correlated count data, with application to analysis of gene expression differences in multi-condition experiments
|
50 | Nicolas Chevrier | Oct 05, 2022 | ||||
GSE206026 |
A single-cell transcriptomic atlas of the human ciliary body
|
3 | lei zeng | Oct 05, 2022 | ||||
GSE195693 |
ATAC-seq essays in A549 and HeLaS3 during cell cycle
|
10 | Yan Zhang | Oct 05, 2022 | ||||
GSE214408 |
ATAC-seq of HRasV12-induced senescence with WSTF overexpression
|
12 | Zhixun Dou | Oct 05, 2022 | ||||
GSE211519 |
Active DNA damage response signaling initiates and maintains meiotic sex chromosome inactivation
|
4 | Satoshi H Namekawa | Oct 05, 2022 | ||||
GSE214617 |
Advanced physiological maturation of iPSC-derived human cardiomyocytes using an algorithm-directed optimization of defined media components
|
29 | Neal I Callaghan | Oct 05, 2022 | ||||
GSE214378 |
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant
|
30 | Eric Vivier | Oct 05, 2022 | ||||
GSE214820 |
Baseline Clinical, Hormonal and Molecular Markers Associated with Clinical Response to IL-23 Antagonism in Hidradenitis Suppurativa
|
26 | John Frew | Oct 05, 2022 | ||||
GSE95553 |
Biphasic Cell Cycle Defect Causes Impaired Neurogenesis in Down Syndrome
|
23 | Nishant Singhal | Oct 05, 2022 | ||||
GSE95552 |
Biphasic Cell Cycle Defect Causes Impaired Neurogenesis in Down Syndrome [CPC RNA-Seq]
|
6 | Nishant Singhal | Oct 05, 2022 | ||||
GSE95550 |
Biphasic Cell Cycle Defect Causes Impaired Neurogenesis in Down Syndrome [PAX6 ChIP-Seq]
|
2 | Nishant Singhal | Oct 05, 2022 | ||||
GSE95551 |
Biphasic Cell Cycle Defect Causes Impaired Neurogenesis in Down Syndrome [Pluripotency, RNA-Seq]
|
15 | Nishant Singhal | Oct 05, 2022 | ||||
GSE186124 |
Bulk RNA sequencing to characterize female hES cells with null DNMT3A/3B deletion
|
8 | Atsushi Fukuda | Oct 05, 2022 | ||||
GSE197851 |
CAR Density Influences Antitumoral Efficacy of BCMA CAR T Cells and Correlates with Clinical Outcome
|
54 | Juan R Rodriguez-Madoz | Oct 05, 2022 | ||||
GSE197849 |
CAR Density Influences Antitumoral Efficacy of BCMA CAR T Cells and Correlates with Clinical Outcome [ATAC-seq]
|
24 | Juan R Rodriguez-Madoz | Oct 05, 2022 | ||||
GSE197843 |
CAR Density Influences Antitumoral Efficacy of BCMA CAR T Cells and Correlates with Clinical Outcome [RNA-seq]
|
24 | Juan R Rodriguez-Madoz | Oct 05, 2022 | ||||
GSE197848 |
CAR Density Influences Antitumoral Efficacy of BCMA CAR T Cells and Correlates with Clinical Outcome [scRNA-seq]
|
6 | Juan R Rodriguez-Madoz | Oct 05, 2022 | ||||
GSE201728 |
CD4 T cell ChIPseq (H3k27ac) and RARα
|
12 | Chang Kim | Oct 05, 2022 | ||||
GSE201729 |
CD4 T cell transcriptome and RARα
|
12 | Chang Kim | Oct 05, 2022 | ||||
GSE211604 |
ChIP-seq analysis of ETV3 and ETV6 in monocyte-derived cells
|
6 | Javiera Villar | Oct 05, 2022 |